AIA
GH icon

Arcadia Investment Advisors’s Guardant Health GH Stock Holding History

Arcadia Investment Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4
Closed -$497 – 157
2021
Q2 		$497 Buy
+4
New +$538 ﹤0.01% 223

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Arcadia Investment Advisors's GH Position: Q3 2021 in Review

Arcadia Investment Advisors sold out of Guardant Health (GH) in Q3 2021, closing a stake of 4 shares — an estimated $497 sold.

Arcadia Investment Advisors first reported a position in GH in Q2 2021 and held it in 1 quarter. The position peaked at $497 in Q2 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Arcadia Investment Advisors reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Arcadia Investment Advisors sold 4 Guardant Health shares in Q3 2021, an estimated $497.
  • Arcadia Investment Advisors first reported a position in Guardant Health in Q2 2021 and held it in 1 quarter.
  • Arcadia Investment Advisors's Guardant Health position peaked at $497 in Q2 2021.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Arcadia Investment Advisors's 13F filing for Q3 2021, filed 19 Dec 2024.